Triplet excited states exhibit strongly medium-dependent properties, which turns them into valuable tools to probe the microenvironments existing in protein binding Finally, protein encapsulation can also modify the photoreactivity of the guest. This is illustrated by presenting an example of retarded photooxidation.
Introduction
In the laser flash photolysis (LFP) technique, a short pulse of light (nano or femtoseconds) from a laser is used to interact with a sample that is located in the optical path of a spectrometer; the result of this interaction can be either a transient absorption or emission process. The signal detected following laser excitation of a substrate may be due to a variety of transient species such as i) triplet excited states (TES) formed after electronic excitation followed by intersystem crossing, ii) radicals obtained by homolytic bond cleavage, iii) radical ions resulting from electron transfer, iv) isomers obtained after rearrangement, etc.
1 (Scheme 1). Drugs suitable for monitoring TES within proteins should possess a chromophore able to absorb the laser irradiation, with a non-negligible intersystem crossing quantum yield and a triplet lifetime in the nanosecond-microsecond time scale. For this purpose, drugs containing chromophores such as biphenyl (flurbiprofen), naphthalene (naproxen, cinacalcet, propranolol, nabumetone) or anthracene (anthracenealkanoic acids) are specially appropriate. As additional requirements, the protein should not absorb or it should not produce any signal in the wavelength region where the drug intermediates do, and the product of the molar absorption coefficient of the excited state by the intersystem crossing quantum yield has to remain constant in the absence and presence of protein.
Most of the work on the use of TES for obtaining relevant bio(chemical) information has been done with transport proteins (TP), such as human and bovine serum albumin (HSA, BSA) or 1-acid glycoproteins (HAAG, BAAG). These proteins are very abundant in plasma and are responsible for a variety of relevant processes, although one of their most important physiological roles is to carry different agents (i.e. drugs or metabolites) in the bloodstream for their selective delivery to specific targets. 2, 3, 4 In addition, the role of plasma protein binding has been recognized as an important factor in drug disposition and efficacy. 5 In this context, drug binding to TP is a key process, which is involved in phenomena such as modulation of drugs solubility in plasma, toxicity, in vivo half-life, etc. 6 Concerning serum albumins, they are major carriers of small organic molecules, which bind primarily to two high-affinity sites (called site I or warfarin binding site and site II or indole-benzodiazepine binding site), with typical association constants in the range of 10 4 -10 6 M -1 . 7 As regards 1-acid glycoproteins, their concentration in serum is much lower than that of albumins. For HAAG, up to seven binding sites have been described, although most small organic molecules bind exclusively to one of them. 8, 9 This high-affinity site is large and flexible, and the areas for basic, acid, and neutral drugs overlap. For BAAG, a substantial overlap of a basic drug and a steroid hormone binding sites has been described. In this context, LFP-based methodologies have been developed to assess protein occupancy in the presence of one or two different transport proteins and to reveal drugdrug interactions between two drugs that share a common protein binding site. and 35.9 ms (minor and major components, respectively).
They are ascribed to FBP within site I (I) and site II (II) of HSA, respectively, based on the known higher affinity of FBP for site II. 17 To obtain independent evidence 
Determination of drug distribution in a binary protein system
A new methodology aimed at a rapid and reliable assessment of drug distribution between two proteins present simultaneously in a biological medium has been developed, based on the determination of the relative contributions of the triplet lifetime components Occupancy rate in (S)-FBP/HSA systems obtained from the decay curves in the presence of serum albumin/glycoprotein binary systems. 20 A representative example is provided by the study of three naphthalenederived drugs, 21 with a (known) different affinity for the two types of proteins: cinacalcet (CIN, a calcimimetic), 22 naproxen (NPX, a NSAID) 23 and propranolol (PPN, an antihypertensive). 24 Their chemical structures can be found in Chart 1.
Prior to analysis of the binary systems, the binding behavior in the presence of isolated proteins is established. Starting with CIN, the excited states of the (R)-enantiomer have been characterized in order to obtain relevant information about its complexation with HSA. 25 Upon LFP of (R)-CIN@HSA (lexc = 308 nm, air), naphthalene-like TES are generated, with absorption maxima at 420 nm. The corresponding decays are satisfactorily fitted using a function containing two monoexponential terms, corresponding to a short-lived and a long-lived component (8 ms and 37 ms, respectively), different from the value found in pure PBS (1.9 ms), indicating that the drug is The results demonstrate that albumins are the major carriers for NPX, while PPN binds preferentially to glycoproteins. An intermediate situation is found for CIN, which presents comparable affinity for both types of proteins. Figure 6 shows the decay kinetics of drugs and the drug distribution at 1/0.5/0.5 drug/HSA/HAAG molar ratio. 
Drug-drug interactions revealed by triplet-triplet energy transfer
The feasibility of drug-drug interactions (DDI) within the binding sites of TP has been probed by TAS, using drug pairs (CIN/PPN and CIN/NAB) complexed within HAAG or BAAG. 26 The concept involves detection of triplet-triplet energy transfer (TTET), which 
Reactivity upon protein complexation
The use of proteins as supramolecular systems to influence the course of organic reactions has attracted increasing interest over the last decades. Specifically, the photoreactivity of encapsulated substrates can be modified by providing protection from attack by oxygen or other external reagents, by imposing conformational restrictions in the binding pockets, or by influencing the stereochemical outcome through the supply of a chiral source. Two examples demonstrating the concept are presented below.
Monitoring the enzyme-like activity of HSA
The -1-O-acyl glucuronide metabolites are intrinsically reactive molecules (both in vivo and in vitro) that can undergo a number of reactions; by far, hydrolysis back to the parent aglycon is the predominating process. 28 This reaction can be catalyzed by several agents (-glucuronidases, esterases, etc.) resulting in a futile cycle, since plasma clearance is the result of competition between conjugation of the parent drug, deconjugation of the glucuronide, and renal clearance. After establishing that the methodology is suitable to discriminate between the drug and its metabolite, LFP has been applied to investigate in situ the glucuronidase activity of HSA at physiological temperature (37 ºC). Since the amount of complexed glucuronide is higher in an excess of albumin, the 1:3.33 ratio is chosen to monitor the reaction. Assuming that AI/AII remains constant for FPB, the preexponential factors and consequently the percentages of (R)-FBP and (2R)-FBPGluc, can be obtained. The course of the reaction, expressed as the percentages of the various species at different times, is represented in Figure 8 . Similar studies conducted at 22 ºC in the presence of protein or at 37 ºC in the absence of HSA show a much slower process.
Enhanced drug photostability of the ligand upon protein encapsulation
Photooxidation of 9-anthaceneacetic acid (ANA, Chart 1) has been examined using different transport proteins such as HSA, BSA, HAAG and BAAG at 1:1 molar ratio. 31 Irradiation of ANA in aerated PBS solutions yields anthraquinone through TTET from 3 ANA* to molecular oxygen, generating singlet oxygen ( 1 O2). This species reacts with the central anthracene ring of ANA leading to an endoperoxide which undergoes rearrangement followed by cleavage of the 9-substituent to afford anthraquinone (ANQ), as summarized in Scheme 2. 
Conclusions
Binding to proteins plays an important role in the pharmacological activity, conformational restrictions, by making use of the amino acid residues as active centers, or by supplying a chiral source.
In this review, some examples of the use of TES to obtain relevant information have been described. The technique has also been successfully employed for other purposes, such as the drug photobinding to proteins in photoallergy, 32 determination of enantiomeric composition in mixtures of enantiomers 33 or inhibition of ligand deprotonation after protein encapsulation. 34 
